| Literature DB >> 35518011 |
Mariam Moussa1, Weaam Ebrahim1,2, Michele Bonus3, Holger Gohlke3,4, Attila Mándi5, Tibor Kurtán5, Rudolf Hartmann6, Rainer Kalscheuer1, Wenhan Lin7, Zhen Liu1, Peter Proksch1.
Abstract
Co-cultivation of the endophytic fungus Fusarium tricinctum with Streptomyces lividans on solid rice medium led to the production of four new naphthoquinone dimers, fusatricinones A-D (1-4), and a new lateropyrone derivative, dihydrolateropyrone (5), that were not detected in axenic fungal controls. In addition, four known cryptic compounds, zearalenone (7), (-)-citreoisocoumarin (8), macrocarpon C (9) and 7-hydroxy-2-(2-hydroxypropyl)-5-methylchromone (10), that were likewise undetectable in extracts from fungal controls, were obtained from the co-culture extracts. The known antibiotically active compound lateropyrone (6), the depsipeptides enniatins B (11), B1 (12) and A1 (13), and the lipopeptide fusaristatin A (14), that were present in axenic fungal controls and in co-culture extracts, were upregulated in the latter. The structures of the new compounds were elucidated by 1D and 2D NMR spectra as well as by HRESIMS data. The relative and absolute configuration of dihydrolateropyrone (5) was elucidated by TDDFT-ECD calculations. This journal is © The Royal Society of Chemistry.Entities:
Year: 2019 PMID: 35518011 PMCID: PMC9060880 DOI: 10.1039/c8ra09067j
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Structures of compounds 1–10.
Yield of induced metabolites per flask of co-culture of F. tricinctum and S. lividans (n = 6) vs. axenic controls of F. tricinctum (n = 4)
| Compound | Fungal control (mg) | Co-culture (mg) | Increase (fold) |
|---|---|---|---|
| 1 | n.d. | 7.67 ± 0.1 | |
| 2 | n.d. | + | |
| 3 | n.d. | + | |
| 4 | n.d. | + | |
| 5 | n.d. | + | |
| 6 | 1.3 ± n.a. | 17.0 ± 0.8 | 12.5 |
| 7 | n.d. | + | |
| 8 | n.d. | 12.5 ± 10.4 | |
| 9 | n.d. | + | |
| 10 | n.d. | + | |
| 11 | 250.7 ± 50.2 | 868.9 ± 38.0 | 3.5 |
| 12 | 203.8 ± 31.8 | 459.5 ± 25.3 | 2.3 |
| 13 | 47.6 ± 32.3 | 95.7 ± 8.9 | 2.0 |
| 14 | 175.2 ± 54.0 | 294.8 ± 11.4 | 1.7 |
n.d. = not detected.
n.a. = not available.
Isolated but not detected in all crude extracts.
NMR data of compound 1a
| Position | 1a | 1b | ||
|---|---|---|---|---|
|
|
|
|
| |
| 1/1′ | 179.5, C | 179.5, C | ||
| 2/2′ | 159.0, C | 159.0, C | ||
| 3/3′ | 121.2, C | 121.2, C | ||
| 4/4′ | 188.3, C | 188.3, C | ||
| 5/5′ | 145.4, C | 145.4, C | ||
| 6/6′ | 139.8, C | 139.8, C | ||
| 7/7′ | 152.8, C | 152.8, C | ||
| 8/8′ | 102.5, CH | 7.17, s | 102.5, CH | 7.17, s |
| 9/9′ | 127.2, C | 127.2, C | ||
| 10/10′ | 112.5, C | 112.5, C | ||
| 11 | 120.4, C | 120.4, C | ||
| 12 | 43.5, CH2 | 3.03, s | 43.5, CH2 | 3.03, s |
| 13 | 169.9, C | 169.9, C | ||
| 14 | 24.8, CH3 | 1.88, s | 24.8, CH3 | 1.88, s |
| 15 | 61.6, CH3 | 4.10, s | 61.6, CH3 | 4.09, s |
| 11′ | 120.1, C | 120.1, C | ||
| 12′ | 43.3, CH2 | 3.08, s | 43.3, CH2 | 3.08, s |
| 13′ | 168.5, C | 168.5, C | ||
| 14′ | 25.1, CH3 | 1.86, s | 25.1, CH3 | 1.86, s |
| 15′ | 61.6, CH3 | 4.09, s | 61.6, CH3 | 4.09, s |
| 16′ | 52.5, CH3 | 3.68, s | 52.5, CH3 | 3.68, s |
Measured in CDCl3–CD3OD (2 : 1) (1H at 600 MHz and 13C at 150 MHz).
NMR data of compound 2a
| Position | 2a | 2b | ||
|---|---|---|---|---|
|
|
|
|
| |
| 1/1′ | 179.1, C | 179.1, C | ||
| 2/2′ | 158.6, C | 158.6, C | ||
| 3/3′ | n.d. | n.d. | ||
| 4/4′ | 188.3, C | 188.3, C | ||
| 5/5′ | 145.5, C | 145.5, C | ||
| 6/6′ | 139.1, C | 139.1, C | ||
| 7/7′ | 152.1, C | 152.1, C | ||
| 8/8′ | 102.0, CH | 7.21, s | 102.0, CH | 7.20, s |
| 9/9′ | 127.1, C | 127.1, C | ||
| 10/10′ | 112.2, C | 112.2, C | ||
| 11/11′ | 119.2, C | 119.2, C | ||
| 12/12′ | 42.9, CH2 | 3.12, s | 42.9, CH2 | 3.10, s |
| 13/13′ | 171.4, C | 171.4, C | ||
| 14/14′ | 24.6, CH3 | 1.91, s | 24.6, CH3 | 1.88, s |
| 15/15′ | 61.2, CH3 | 4.13, s | 61.2, CH3 | 4.12, s |
| OH-5/OH-5′ | 12.06, s | 12.06, s | ||
Measured in CDCl3 (1H at 600 MHz and 13C at 150 MHz).
Data were extracted from the HSQC and HMBC spectra.
n.d. = not detected.
NMR data of compound 3a
| Position | 3a | 3b | ||
|---|---|---|---|---|
|
|
|
|
| |
| 1/1′ | 179.3, C | 179.3, C | ||
| 2/2′ | 158.7, C | 158.7, C | ||
| 3/3′ | n.d. | n.d. | ||
| 4/4′ | n.d. | n.d. | ||
| 5/5′ | 145.4, C | 145.4, C | ||
| 6/6′ | 139.3, C | 139.3, C | ||
| 7/7′ | 152.6, C | 152.6, C | ||
| 8/8′ | 102.0, CH | 7.21, s | 102.0, CH | 7.21, s |
| 9/9′ | 127.6, C | 127.6, C | ||
| 10/10′ | 112.1, C | 112.1, C | ||
| 11/11′ | 119.5, C | 119.5, C | ||
| 12/12′ | 43.3, CH2 | 3.07, s | 43.3, CH2 | 3.06, s |
| 13/13′ | 167.6, C | 167.6, C | ||
| 14/14′ | 24.7, CH3 | 1.90, s | 24.7, CH3 | 1.89, s |
| 15/15′ | 61.2, CH3 | 4.13, s | 61.2, CH3 | 4.12, s |
| 16/16′ | 52.0, CH3 | 3.71, s | 52.0, CH3 | 3.71, s |
| OH-5/OH-5′ | 12.05, s | 12.05, s | ||
Measured in CDCl3 (1H at 600 MHz and 13C at 150 MHz).
Data were extracted from the HSQC and HMBC spectra.
n.d. = not detected.
NMR data of compound 4a
| Position | 4a | 4b | ||
|---|---|---|---|---|
|
|
|
|
| |
| 1 | 179.0, C | 179.0, C | ||
| 2 | 158.5, C | 158.5, C | ||
| 3 | n.d. | n.d. | ||
| 4 | n.d. | n.d. | ||
| 5 | 143.8, C | 143.8, C | ||
| 6 | 139.3, C | 139.3, C | ||
| 7 | 152.4, C | 152.4, C | ||
| 8 | 101.1, CH | 7.16, s | 101.1, CH | 7.16, s |
| 9 | n.d. | n.d. | ||
| 10 | 111.8, C | 111.8, C | ||
| 11 | 120.0, C | 120.0, C | ||
| 12 | 42.1, CH2 | 3.29, s | 42.1, CH2 | 3.28, s |
| 13 | 167.9, C | 167.9, C | ||
| 14 | 24.2, CH3 | 1.82, s | 24.2, CH3 | 1.81, s |
| 15 | 60.4, CH3 | 3.96, s | 60.4, CH3 | 3.95, s |
| 16 | 52.0, CH3 | 3.57, s | 52.0, CH3 | 3.56, s |
| OH-5 | 11.80, s | 11.79, s | ||
| 1′ | 178.6, C | 178.6, C | ||
| 2′ | 157.8, C | 157.8, C | ||
| 3′ | n.d. | n.d. | ||
| 4′ | n.d. | n.d. | ||
| 5′ | n.d. | n.d. | ||
| 6′ | 140.2, C | 140.2, C | ||
| 7′ | 144.3, C | 144.3, C | ||
| 8′ | 111.4, CH | 7.23, s | 111.4, CH | 7.23, s |
| 9′ | n.d. | n.d. | ||
| 10′ | 107.6, C | 107.6, C | ||
| 11′ | 120.0, C | 120.0, C | ||
| 12′ | 41.8, CH2 | 3.24, s | 41.8, CH2 | 3.24, s |
| 13′ | 167.9, C | 167.9, C | ||
| 14′ | 24.6, CH3 | 1.80, s | 24.6, CH3 | 1.80, s |
| 15′ | 60.7, CH3 | 4.01, s | 60.7, CH3 | 4.00, s |
| 16′ | 52.0, CH3 | 3.59, s | 52.0, CH3 | 3.59, s |
| OH-7′ | 11.10, s | 11.10, s | ||
Measured in DMSO-d6 (1H at 600 MHz and 13C at 150 MHz).
Data were extracted from the HSQC and HMBC spectra.
n.d. = not detected.
Fig. 2Calculation of the height of the rotation barrier for compounds 1–4. (A) Conformational energy profile obtained for the gas phase at the B3LYP/6-31G(d) level of theory for the rotation about the central biaryl bond in the model compound 8,8′-dihydroxy-3,3′-dimethoxy-2,2′-binaphthyl-1,1′,4,4′-tetrone. Vertical lines separate regions of values for the torsion angle that correspond to distinct conformations according to the Klyne–Prelog notation. The structures of the Ra and Sa atropisomers are assigned to the corresponding minimum-energy conformers in the anticlinal conformations. (B) Visualization of the distinct conformers according to the Klyne–Prelog notation. The height of the black line indicates the relative energy of the depicted conformer.
Fig. 3Stereochemical relationship of atropisomers in the case of the symmetric molecules 2 and 3. If both molecule halves are homomorph (A), diastereomeric atropisomers result. If both molecule halves are enantiomorph (B), enantiomeric atropisomers result. “Me” and “OMe” relate to C-14 and 15 as well as C-14′ and 15′ in Fig. 1. The grey arrows in the right panel indicate whole-body rotations; the configuration descriptors relate to the central/axial/central chirality elements in the molecules.
NMR data of compound 5a
| Position |
|
|
|---|---|---|
| 2 | 170.9, C | |
| 3 | 109.6, CH | 6.36, s |
| 4 | 184.4, C | |
| 4a | 113.1, C | |
| 5 | n.d. | |
| 5a | n.d. | |
| 6 | 168.6, CH | |
| 8 | 81.8, CH | 6.04, br s |
| 9 | 70.9, CH | 4.92, br s |
| 9a | 125.6, C | |
| 10 | 103.6, CH | 7.38, s |
| 10a | 158.1, C | |
| 11 | 170.6, C | |
| 12 | 20.3, CH3 | 2.51, s |
| OMe-11 | 52.4, CH3 | 3.73, s |
Measured in acetone-d6 (1H at 750 MHz and 13C at 175 MHz).
Data were extracted from the HSQC and HMBC spectra.
n.d. = not detected.
Fig. 4Experimental ECD spectrum of 5 in MeCN compared with the Boltzmann-weighted BH&HLYP/TZVP PCM/MeCN//CAM-B3LYP/TZVP PCM/MeCN spectrum of the cis-(8R,9S)-5.
Fig. 5Experimental ECD spectrum of 5 in MeCN compared with the Boltzmann-weighted BH&HLYP/TZVP PCM/MeCN//CAM-B3LYP/TZVP PCM/MeCN spectrum of the trans-(8S,9S)-5.